Unity Subcutaneous Infusion System For Remodulin

Infusion Pump, Drug Specific, Pharmacy-filled

DEKA Research & Development

The following data is part of a premarket notification filed by Deka Research & Development with the FDA for Unity Subcutaneous Infusion System For Remodulin.

Pre-market Notification Details

Device IDK191313
510k NumberK191313
Device Name:Unity Subcutaneous Infusion System For Remodulin
ClassificationInfusion Pump, Drug Specific, Pharmacy-filled
Applicant DEKA Research & Development 340 Commercial Street Manchester,  NH  03101
ContactJason Demers
CorrespondentJason Demers
DEKA Research & Development 340 Commercial Street Manchester,  NH  03101
Product CodeQJY  
CFR Regulation Number880.5725 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2019-05-15
Decision Date2020-02-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.